Allergic Rhinitis Treatment: Cetirizine vs. Diphenhydramine
Second-generation antihistamines like cetirizine (Zyrtec) should be used as first-line treatment for allergic rhinitis, while first-generation antihistamines like diphenhydramine (Benadryl) should be avoided due to their sedating effects and potential for impairment. 1
Comparative Efficacy and Safety
Second-Generation Antihistamines (Cetirizine/Zyrtec)
- Cetirizine is recommended by the American Academy of Allergy, Asthma, and Immunology as the most effective OTC oral medication for severe seasonal allergies 1
- More effective than other second-generation options in reducing rhinitis symptom scores 1
- May cause mild drowsiness in some patients (13.7% vs 6.3% with placebo) 1
- Provides effective control of symptoms such as sneezing, rhinorrhea, and nasal pruritus 1
- Once-daily dosing improves adherence 2
First-Generation Antihistamines (Diphenhydramine/Benadryl)
- Produces significant sedation and impairment 3
- Worsens sleep architecture 3
- Has anticholinergic side effects that can be problematic, especially in elderly patients 3
- Should not be used as a first-line treatment due to safety concerns 1, 3
Treatment Algorithm for Allergic Rhinitis
Mild Intermittent or Mild Persistent Symptoms:
Moderate to Severe Persistent Symptoms:
For Predominant Nasal Congestion:
For Patients with Comorbid Asthma:
Important Clinical Considerations
Duration of Treatment: Continue cetirizine for at least 3 months after an episode of allergic rhinitis, with periodic evaluation to determine the need for continued treatment 1
Combination Therapy: The combination of cetirizine with an intranasal corticosteroid may provide better symptom control than either medication alone for patients with moderate to severe symptoms 1
Avoid Concurrent Use: Using both cetirizine and diphenhydramine simultaneously is not recommended as it provides no additional benefit and increases the risk of side effects 3
Special Populations:
Common Pitfalls to Avoid
Using first-generation antihistamines as first-line therapy - These should be avoided due to sedation and impairment issues 3
Prolonged use of nasal decongestants - Can lead to rhinitis medicamentosa (rebound congestion) 1
Inadequate treatment duration - Treatment should continue for at least 3 months for optimal benefit 1
Overlooking comorbid conditions - Allergic rhinitis often coexists with asthma and requires coordinated treatment 4, 1
Failing to recommend allergen avoidance - Environmental control measures should accompany pharmacotherapy 1